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12-48m lesion status 12-48m* Incident KL1
Number (%) with outcome
Adjusted OR** (95% CI), 12-48m
change (vs no change)
48-84m Persistent symptoms
Number (%) with outcome
Adjusted OR*** (95% CI), 12-48m
change (vs. no change)
TF cartiiaqe darnaqe
None/ none 13/394 (3.3) reference 54/420 (12.9) reference
Damage/ no change 21/339 (6.2) 88/356 (24.7)
None/ incident damage 8/40(20.0) 6.15(3.12, 12.14) 11/45(24.4) 2.11 (1.26, 3.51)
Damage/ worse 9/26 (34.6) 14/28 (50.0)
PF cartilage damage
None/ none 12/269 (4.5) reference 29/287(10.1) reference
Damage/ no change 30/443(6.8) 123/470 (26.2)
None/ incident damage 7/37(18.9) 2.00 (0.93, 4.34) 9/39 (23.1) 1.91 (1.20, 3.06)
Damage/ worse 2/50 (4.0) 19/53 (35.9)
Meniscal tear
None/ none 18/596 (3 .0) reference 91/628 (14.5) reference
Tsar/ no change 18/151 (11.9) 48/164 (28 3)
None/ incident tear 11/40 (27 5) 7.67(3.72, 15.82.) 9/41 (22.0) 1.37 (0.75,2.50)
Tear/worse 4/12 (33.3) 7/16 (43.8)
Meniscal extrusion
None/ none 27/669 (4.0) reference 109/7I3 (15.3) reference
Extrusion/ no change 15/105 (14.3) 38/110 (34 6)
None/ incident extrusion 6/19(31.6) 10.46 (4.24, 2575) 2/19 (10.5) 0.96 (0.38, 2.44)
Extrusion/ worse 3/6 (50.0) 3/7 (42.9)
TF BMLs
None/ none 23/524 (4 4) reference 77/557 (13.8) reference
BML/ no change 14/203 (6 9) 59/215 (27 4)
None/ incident BML 11/83 (17 5) 5.24(2 .SO, 10.54) 13/66 (19.7) 1.18 (0.68,2.03)
BML/ worse 3/9 (33.3) 6/11 (54,6)
PF BMLs
None/ none 17/323 (5.3) reference 40/348 (11.5) reference
BML/ no change 23/353 (6.5) 98/374 (26 2)
None/ incident BML 5/64 (7.8) 1.62 (0.79, 3.32) 11/66 (16.7) 1.75 (1.15, 2.66)
BML/ worse 6/59 (10.2) 24/61 (33.3)
m ¼ month, KL ¼ Kellgren and Lawrence, OR ¼ odds ratio, CI ¼ conﬁdence interval, TF ¼ tibiofemoral, PF ¼ patellofemoral
*At time of abstract preparation, 48m is latest OAI x-ray data release
**Adjusted OR (shown in this column) is the adjusted odds of incident KL  1 lesions for knees with 12-48m lesion status change, compared to the odds for knees with no
lesions or stable lesion status (reference group) over the same 3-year interval (columns 2 and 3), adjusted for age, gender, BMI, knee injury, and knee surgery.
***Adjusted OR (shown in this column) is the adjusted odds of persistent symptoms over 48-84m follow-up for knees with 12-48m lesion status change, compared to the odds
for knees with no lesions or stable lesion status over 12-48m (columns 4 and 5), adjusted for age, gender, BMI, knee injury, and knee surgery.
Figure 1. Micro-CT vs. Synchrotron KES-SRmCT. The left pane shows micro-
CT derived transverse 2-D section of the distal femoral condyle 12 weeks
post-surgery. Despite the evident formation of osteophytes (arrows) and
thickening of the subchondral bone plate (square bracket) to the trained
eye, most information is purely morphometric in nature, with no direct
evidence of adaptive bone turnover. On the other hand, the right hand
side panel indicates a 3-D render of strontium distribution in spatial
regions of dynamic bone turnover (light blue color) using KES-SRmCT, in
conjunction with that micro-CT based morphometric information.
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SYNCHROTRON-BASED 3-D FUNCTIONAL MICRO-CT IMAGING OF
DYNAMIC STRONTIUM LABEL TO LOCALIZE PATHOLOGICAL BONE
ADAPTATIONS IN POST-TRAUMATIC OSTEOARTHRITIS
A. Panahifar y,z, D.M. Cooper z, M.R. Doschak y. yUniv. of Alberta,
Edmonton, AB, Canada; zUniv. of Saskatchewan, Saskatoon, SK, Canada
Purpose: Early diagnosis of osteoarthritis using medical imaging has
been a focus of many studies, but results have been inconclusive, partly
due to the unknown etiology of the disease. In this study we aimed to
image pathological bone mineralization and remodeling in 3 dimen-
sions (3-D) during the pathogenesis of the disease, at a resolution and
spatial accuracy far better than conventional radionuclide-based
imaging methods. Non-radioactive strontium, an element with an
afﬁnity for bone uptake, was employed as a dynamic functional imaging
tracer of bone turnover and its distribution in bone was evaluated using
an x-ray-based method at the Canadian Light Source synchrotron called
dual energy K-edge subtraction micro-CT (KES-SRmCT).
Methods: A total of 16 adult female rats were used in the study. Post
traumatic osteoarthritis was induced in 12 rats by surgically transecting
medial collateral and anterior cruciate ligaments, and removing medial
meniscus. The remaining 4 ratswere assessed as sham-operated controls.
Bone adaptations were assessed by in vivo micro-CT imaging at monthly
intervals for 12 weeks. In order to visualize pathological bone minerali-
zation, rats received daily oral administration of strontium as a dynamic
tracer localizing tobone turnoverand thedistributionof that strontiumin
bones was assessed in 3-D and at 10mm resolution using KES-SRmCT. A
synchrotron monochromatic x-ray source allowed for precise tunability
of x-rayenergies, itwasused to imagebothbelowandabove theK-edgeof
strontium, the subtraction of which produced elemental distribution of
strontiumwithin bone in 3-D. The results were correlated with 2-D ele-
mental mapping using electron probe micro-analysis (EPMA) at 5mm
resolution and decalciﬁed histological evaluation.
Results: Under conventional in vivo micro-CT, temporal morphometric
changes in bone during the pathogenesis of osteoarthritis includedconsiderable osteophyte formation around the collateral ligament
attachments and margins of articulating surfaces, as well as sclerosis of
subchondral bone at later stages. In contrast, using KES-SRmCT imaging,
distinct micro-architectural bony surfaces signiﬁcantly incorporated
strontium label, notably mineralizing osteophytes at 4, 8, and 12 weeks
post-surgery (Figure 1) and thickening of the subchondral bone plate
between weeks 8 to 12 (Figure 2). In the sham-operated group, stron-
tium was scantily deposited on adaptive trabecular surfaces indicating
normal bone remodeling.
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tium at sub-therapeutic doses can serve effectively as a dynamic tracer of
bone turnover to assess micro-structural changes associated with the
pathogenesis of bone disease including osteoarthritis, at high spatial
resolution (micron level) not possible with radionuclide-based scinti-
graphic imaging. In addition, when co-administered with drug inter-
ventions, strontium as a dynamic label could be used to gauge the
efﬁcacy of disease modifying drugs upon adaptive bone physiology in
osteoarthritis or other adaptive bone pathology, such as osteolytic/
sclerotic bone cancer metastases. The KES-SRmCT imaging procedure
reported here is the ﬁrst application of synchrotronmicro-CT to segment
and visualize regions of active bone turnover in osteoarthritis in 3-D.
Figure 2. Subchondral sclerosis in end-stage osteoarthritis. Note sig-
niﬁcant incorporation of strontium in subchondral bone detected by
EPMA (light blue color) from week 8 (a) to 12 (b) post-surgery. The cor-
responding histology (Safranin-O stain) indicates sclerotic subchondral
bone (note lack of marrow space) and full thickness loss of articular car-
tilage.
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ACTIVIN RECEPTOR-LIKE KINASE ALK5 AND ALK1 ARE BOTH
REQUIRED FOR TGFb-INITIATED CHONDROGENIC
DIFFERENTIATION OF MESENCHYMAL STEM CELLS
L.M. de Kroon y,z, E. N. Blaney Davidson y, R. Narcisi z,
H.M. van Beuningen y, G.J. van Osch z, P.M. van der Kraan y. yRadboud
Univ. Med. Ctr., Nijmegen, Netherlands; z Erasmus Univ. Med. Ctr.,
Rotterdam, Netherlands
Purpose: Cartilage matrix defects, due to osteoarthritis or trauma, are
not repaired because chondrocytes have poor regenerative capacity.
Bone marrow-derived mesenchymal stem cells (BMSCs) are a promis-
ing cell source to treat matrix defects due to their capacity to differ-
entiate into chondrocytes. Transforming Growth Factor-b (TGFb)
potently initiates chondrogenic differentiation of BMSCs and is known
to signal either via Activin receptor-Like Kinase (ALK) receptor ALK5 or
ALK1, which activate the intracellular SMAD2/3 and SMAD1/5/8 path-
way respectively. Since the role of TGFb receptors in BMSC chondro-
genesis is unknown, we investigated whether either ALK5 or ALK1 is
crucial to initiate chondrogenic differentiation of BMSCs.
Methods: Human fetal BMSCs (purchased from ScienCell) were trans-
duced with either adenoviral constitutive active (ca)ALK5, caALK1 or
LacZ (control) for receptor overexpression. To downregulate receptor
expression, BMSCs were transfected with lentiviral ALK5-shRNA, ALK1-
shRNA or a vector without shRNA (control). After viral infection, BMSCs
were pellet-cultured in serum-free chondrogenic medium for 7 days.
All aforementioned conditions were stimulated with 10 ng/mL TGFb1,
which initiates chondrogenic differentiation. Cells overexpressing
either caALK5 or caALK1 were cultured without TGFb1 stimulation inorder to determine whether constitutive active receptor signaling ini-
tiated BMSC chondrogenesis. To verify chondrogenic differentiation,
aggrecan gene expression (ACAN) was measured and proteoglycan
deposition was evaluated by Safranin O staining.
Results: Chondrogenesis was observed in LacZ-transfected BMSC pel-
lets (LacZ-BMSCs) stimulated with TGFb1 as measured by high ACAN
expression and positive proteoglycan staining. Overexpressing either
caALK5 or caALK1 without stimulating BMSCs with TGFb1 resulted in
activation of the SMAD2/3 or SMAD1/5/8 pathway respectively. How-
ever, unstimulated caALK1-BMSCs had ~8-fold and caALK5-BMSCs had
~78-fold lower ACAN expression and proteoglycan staining was absent
compared to LacZ-BMSCs that were stimulated with TGFb1. Down-
regulating either ALK1 or ALK5 by shRNA in TGFb1-stimulated BMSCs
caused respectively ~18-fold and ~222-fold lower ACAN expression
levels than in the control condition and an absence of proteoglycan
staining.
Conclusions: Our data suggest that TGFb needs to activate both its ALK5
and ALK1 receptor to initiate chondrogenic differentiation of BMSCs.
Both receptors seem crucial as BMSC chondrogenesis was not initiated
when overexpressing either constitutive active ALK5 or ALK1, and
chondrogenesis was inhibited when downregulating either ALK1 or
ALK5. This study helps to better understand the molecular events
induced by TGFb during chondrogenic differentiation of BMSCs, which
is important for improving cartilage matrix formation by mesenchymal
stem cells.
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AGRIN: A NEW PLAYER IN JOINT BIOLOGY AND A POTENT GROWTH
FACTOR FOR CARTILAGE REGENERATION
S.E. Eldridge. WHRI, London, United Kingdom
Purpose: Osteoarthritis is a chronic disabling disease characterized by
cartilage breakdown for which there is no cure. Disruption of the gene
encoding for the heparan sulphate proteoglycan Agrin results in
embryonic skeletal dysplasia suggesting a role for Agrin in cartilage
biology and prompting us to study its role in articular cartilage biology
and osteoarthritis. The aims of this study are to establish the expression
pattern of Agrin in healthy/normal cartilage and compare it to the
expression pattern in osteoarthritic or injured cartilage; determine the
effects of knockdown and over-expression of Agrin within cartilage in
vitro and in vivo and to determine the epistasis of Agrin in articular
chondrocytes.
Methods: Agrin expression was determined by immunohistochemistry
and qPCR. Osteoathritis was induced in 8 week old 129sv mice by
destabilisation of the medial meniscus (DMM) and Agrin expression
was evaluated by immunoﬂuorescence 8 weeks post-surgery. Paired
human samples of preserved cartilage vs severely osteoarthritic car-
tilage were compared by immunoﬂuorescence. Gain and loss of func-
tion experiments were performed using an expression plasmid
encoding mammalian Agrin and siRNAs in C28/I2 and bovine chon-
drocytes in micromass culture. In vivo cartilage formation was
assessed using an ectopic implantation model in nude mice; growth-
arrested COS7 cells overexpressing Agrin or GFP were combined with
bovine chondrocytes (ratio 1:10) and implanted ectopically into nude
mice for two weeks. Retrieved implants were characterised by his-
tology and qPCR.
Results: Agrin and its known receptors were expressed in healthy adult
human articular cartilage and downregulated in human and exper-
imental murine osteoarthritis. Silencing of Agrin by siRNA resulted in
reduced GAG production in C28/I2 and in chondrocyte de-differ-
entiation characterised by decreased expression of SOX9, COL2A1 and
ACAN mRNA. Overexpression of Agrin in the human chondrocyte cell
line C28/I2 and bovine primary articular chondrocytes resulted in
enhanced GAG production and SOX9 upregulation. Importantly, in
contrast to BMP-2, Agrin over-expression did not induce markers of
cartilage hypertrophy including COL10A1 and MMP-13. Delivering
Agrin to primary bovine chondrocytes transplanted in the muscle of
nude mice resulted in enhanced formation of ectopic cartilage, which
did not display signs of hypertrophy, vascular invasion, or endochondral
bone formation.
Conclusions: Our data show that Agrin is essential for the maintenance
of the chondrocytic phenotype and extracellular matrix production
whilst exogenous Agrin enhances chondrocyte differentiation and car-
tilage formation in vitro and in vivo; and therefore may be a valuable
chondrogenic molecule in tissue engineering technologies.
